Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Elutia Inc ELUT

Healthcare Biotechnology
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Device Protection, Women’s Health and Cardiovascular markets. These products are primarily sold to healthcare providers or commercial partners. In Device Protection, it sells CanGaroo, a biological envelope, that is indicated for use... see more

Recent & Breaking News (NDAQ:ELUT)

Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

GlobeNewswire May 10, 2023

Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023

GlobeNewswire May 3, 2023

Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio

GlobeNewswire April 20, 2023

Aziyo Biologics Reports Record Full Year 2022 Revenues

GlobeNewswire March 22, 2023

Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women's Access to Biologics for Soft Tissue Reconstruction

GlobeNewswire March 22, 2023

Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope

GlobeNewswire March 20, 2023

Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023

GlobeNewswire March 15, 2023

Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference

GlobeNewswire February 27, 2023

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire January 31, 2023

Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results

GlobeNewswire January 9, 2023

Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation

GlobeNewswire December 15, 2022

Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock

GlobeNewswire December 1, 2022

Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire November 30, 2022

Aziyo Biologics to Participate in Upcoming Investor Conferences

GlobeNewswire November 21, 2022

Aziyo Biologics Reports Strong Third Quarter 2022 Revenue

GlobeNewswire November 14, 2022

Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022

GlobeNewswire November 7, 2022

Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors

GlobeNewswire October 24, 2022

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire October 18, 2022

Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets

GlobeNewswire October 11, 2022

Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer

GlobeNewswire August 26, 2022